Synthesis, In Vitro Evaluation, and Molecular Docking Studies of Novel 3,5‐Diphenyl‐1H‐1,2,4‐Triazole Derivatives as Potential hEGFR Inhibitors

Documenti analoghi

• The Quest for Ligands Against Kinesin Motor Protein Eg5
  di: Ahmet Fatih Sahin, et al.
  Pubblicazione: (2025)
• Design, Synthesis, and Integrated In Silico–In Vitro Evaluation of Triazole‐Linked Benz/Imidazole‐2‐Thione/Selone Derivatives as Selective CDK1 Inhibitors for Breast Cancer Therapy
  di: Alameer Ezat Abdulkareem, et al.
  Pubblicazione: (2025)
• Exploring the SAR of 1,2,3‐Triazoles as Tumor‐Associated Carbonic Anhydrases IX and XII Inhibitors for Anticancer Applications
  di: Naveen Chauhan, et al.
  Pubblicazione: (2025)
• Design, Synthesis and Evaluation of Indole‐Based 1,2,3‐Triazoles as Potential Quorum Sensing and Biofilm Inhibitors Against Pseudomonas aeruginosa
  di: Kosana Sai Chaitanya, et al.
  Pubblicazione: (2026)
• Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin‐Resistant Endometrial Cancer Cells
  di: Wen Gan, et al.
  Pubblicazione: (2025)